Now-a-days, genetically engineered insulin is being produced at commercial level. The biotechnological procedure involves the synthesis of two DNA sequences corresponding to A and B insulin chains. The two DNA sequences or genes are made to fuse with plasmids and later allowed to form insulin chains.